Monoclonal antibodies blocking CGRP for prevention of migraine
Introduction and purpose Monoclonal antibodies blocking calcitonin gene-related peptide (CGRP) are a novel treatment strategy developed specifically for prevention of migraine. Four drugs belong to this group: eptinezumab, fremanezumab and galcanezumab, which bind to the peptide; and erenumab, w...
-д хадгалсан:
| Үндсэн зохиолчид: | , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Kazimierz Wielki University
2023-04-01
|
| Цуврал: | Journal of Education, Health and Sport |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://apcz.umk.pl/JEHS/article/view/43098 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|